J&J, Teva and Other Opioid Drugmakers Face $50 Billion Lawsuit in California | BioSpace
UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT IN RE TEVA SECURITIES LITIGATION : No. 3:17-cv-00558 (SRU) LONG-FORM NO
Pfizer and Teva face new drug delay action - Global Competition Review
TEVA PHARMACEUTICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva
Irbesartan, Losartan and Valsartan (Azido Impurity) Class Action - Rice Harbut Elliott
Teva settles investor lawsuit for $420m - Globes
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
If you bought Provigilo directly from Cephalon, you could get a
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Does Teva's $15M, 18-year opioid settlement with Louisiana signal the start of a trend? | Fierce Pharma
Teva Settles Price-Fixing-Related Securities Class Action Litigation for $420 Million | The D&O Diary
Teva enters opioid settlement agreement with US state Rhode Island
Teva, Allergan Settle Opioid Lawsuit With West Virginia
Rosen Law Firm Files Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA
Purdue Pharma, others could deduct opioid settlements from taxes
Teva Pharmaceuticals Retirement Savings Plan $2.55M Class Action Settlement - Top Class Actions
Teva Shareholder Notice
Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
Teva Pharmaceutical Industries Settles $420 Million Shareholder Lawsuit
Teva charged in US price-fixing investigation | Financial Times
Teva's U.S. Unit Charged in Generic-Drug Price-Fixing Probe - BNN Bloomberg
Israeli Pension Fund Manager Leads Class Action Against Teva Pharmaceuticals Over Price-Hike and Opioid Scandals | Courthouse News Service
